Anis Tebourbi, Rami Triki, Mouadh Nefiss, Gharbi Mohamed Amine, Ramzi Bouzidi
Department of Orthopedic Surgery, Mongi Slim Hospital La Marsa, La Marsa, Tunisia.
Video J Sports Med. 2024 May 16;4(3):26350254231220953. doi: 10.1177/26350254231220953. eCollection 2024 May-Jun.
Failure rate of meniscal repair can reach 25%. Multiple techniques have been used to increase meniscal healing, notably biological augmentation techniques. One of them is fibrin clot-augmented meniscal repair, which will be described in this video.
This technique is indicated mainly for the lesions with a high failure rate. This includes large, horizontal, and radial tears and even for meniscal cysts, especially in a stable knee. This technique can also be used in revision meniscal suture when failure is no longer an option.
Fibrin clot is prepared from sterile peripheral venous blood from the patient. A plastic syringe is used to stir the blood in a sterile glass container. The fibrin clot is then formed and washed rigorously with saline solution. Rolling the fibrin clot which is fixed to the syringe allows to give the fibrillar aspect of the clot. The formed fibrin clot is now solid enough to be manipulated and can be fixed to a vicryl suture thread allowing it to enter the knee and be fixed inside the meniscal lesion. The clot is wrapped inside the meniscal lesion with inside-out or outside-in suture technique.
We used this technique for multiple types of lesions, like bucket handle meniscal tear, horizontal meniscal cleavage, parrot beak tear, and even in lesions within white-white zone. The postoperative protocol is the same as standard inside-out meniscal repair. This technique has been used in the literature with promising results.
The fibrin clot-augmented meniscal repair is a demanding but promising technique. We need further follow-up to confirm its effectiveness.
The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
半月板修复的失败率可达25%。已采用多种技术来促进半月板愈合,尤其是生物增强技术。其中之一是纤维蛋白凝块增强半月板修复术,本视频将对此进行介绍。
该技术主要适用于失败率较高的损伤。这包括大型、水平和放射状撕裂,甚至半月板囊肿,尤其是在膝关节稳定的情况下。当不再有其他选择时,该技术也可用于半月板缝合翻修术。
纤维蛋白凝块由患者无菌外周静脉血制备。使用塑料注射器在无菌玻璃容器中搅拌血液。然后形成纤维蛋白凝块,并用盐溶液严格冲洗。滚动固定在注射器上的纤维蛋白凝块可使其呈现纤维状外观。形成的纤维蛋白凝块现在足够坚固,可以进行操作,并可固定在一根可吸收缝合线上,使其能够进入膝关节并固定在半月板损伤处。采用由内向外或由外向内缝合技术将凝块包裹在半月板损伤处。
我们将该技术用于多种类型的损伤,如桶柄状半月板撕裂、水平半月板劈裂、鹦鹉嘴状撕裂,甚至在红白区或白白区内的损伤。术后方案与标准的由内向外半月板修复相同。该技术在文献中的应用取得了令人满意的结果。
纤维蛋白凝块增强半月板修复术是一项要求较高但很有前景的技术。我们需要进一步随访以证实其有效性。
作者证明已获得本出版物中出现的任何患者的同意。如果个体可能被识别,作者已随本稿件提交了患者的豁免声明或其他书面批准形式以供发表。